Clinical Trial Update: The Purpose of This Study is to Determine if Eplerenone is Effective in Treatment of Mild to Moderate Heart Failure [Phase 4]

View source ↗

Summary

A Phase 4 trial update assessing whether eplerenone is effective in treating mild to moderate heart failure has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• eplerenone (eplerenone)

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Heart Failure, Congestive | Phase 4 | Status: COMPLETED